Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableTemporarily pausedNCT00493610
What this trial is testing

Mucomyst for Hepatitis C

Who this might be right for
Hepatitis C
US Department of Veterans Affairs 5
Not applicableStudy completedNCT04186260
What this trial is testing

A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men

Who this might be right for
NAFLD
University of Arizona 15
Not applicableStudy completedNCT03156582
What this trial is testing

Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 562
Testing effectiveness (Phase 2)Study completedNCT01438424
What this trial is testing

Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials

Who this might be right for
Hepatitis B VirusHBV
Bristol-Myers Squibb 1,053
Not applicableStudy completedNCT03000023
What this trial is testing

Anticipated and Perceived Benefits Following Hepatitis C Treatment

Who this might be right for
Hepatitis CHepatitis C, Chronic
University of North Carolina, Chapel Hill 100
Testing effectiveness (Phase 2)Study completedNCT00443079
What this trial is testing

Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
Fatty Liver
Heather Patton 6
Not applicableNot Yet RecruitingNCT07734896
What this trial is testing

Evaluating Novel Scoring Systems to Predict Outcomes in Acute-on-Chronic Liver Failure

Who this might be right for
Acute-on-Chronic Liver Failure (ACLF)Liver CirrhosisEnd Stage Liver Disease
Assiut University 100
Not applicableUnknownNCT03386890
What this trial is testing

Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis

Who this might be right for
Nonalcoholic Fatty Liver DiseaseLiver SteatosisLiver Fibrosis
Beijing Friendship Hospital 400
Testing effectiveness (Phase 2)Study completedNCT00377182
What this trial is testing

Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS With or Without COPEGUS in Patients With Chronic Hepatitis C (CHC) Genotype 1 Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 107
Post-approval studies (Phase 4)UnknownNCT00239096
What this trial is testing

Prevention of Decompensation in Liver Cirrhosis

Who this might be right for
Alcoholic Liver CirrhosisAscites
Odense University Hospital 100
Not applicableUnknownNCT06061640
What this trial is testing

The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver Disease
The First Affiliated Hospital of Zhejiang Chinese Medical University 500
Not applicableStudy completedNCT02705118
What this trial is testing

Evaluation of Performance of Automatic Fusion for Radiofrequency Ablation of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
JOON-IL CHOI 82
Early research (Phase 1)UnknownNCT04913090
What this trial is testing

A Phase I Clinical Trial of XZP-5610 Tablets in Healthy Subjects

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
Xuanzhu Biopharmaceutical Co., Ltd. 112
Not applicableUnknownNCT04107324
What this trial is testing

ARAPS Study on Accelerated Liver Regeneration

Who this might be right for
Liver RegenerationLiver CancerLiver Metastases+1 more
University of Aarhus 30
Post-approval studies (Phase 4)WithdrawnNCT01770223
What this trial is testing

Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT03587623
What this trial is testing

Copeptin Serum Level in Liver Transplant Recipients

Who this might be right for
Liver CirrhosisCopeptinLiver Transplant
Medical University of Warsaw 38
Not applicableLooking for participantsNCT02647879
What this trial is testing

Treatment as Prevention for Hepatitis C in Iceland

Who this might be right for
Hepatitis C
Landspitali University Hospital 1,000
Early research (Phase 1)Study completedNCT02565862
What this trial is testing

A Drug-drug Interaction Study Between Daclatasvir and Metformin

Who this might be right for
Hepatitis CDiabetes MellitusInsulin Resistance
Radboud University Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT03318562
What this trial is testing

A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC

Who this might be right for
Triple Negative Breast CancerHepatocellular Carcinoma
Effector Therapeutics 3
Not applicableUnknownNCT04122027
What this trial is testing

A Prospective Randomized Controlled Trial on the Use of Cerebral Oximetry in Adult Chinese Patients Undergoing Liver Transplantation

Who this might be right for
Liver Failure
The University of Hong Kong 158
Next Page